Trump announces deals to cut obesity drug prices and expand Medicare coverage
TL;DR Summary
The Trump administration announced deals with Eli Lilly and Novo Nordisk to lower the prices of blockbuster obesity drugs, making them as affordable as $149 for oral forms and reducing Medicare copays to expand access, with prices set to take effect in mid-2026, as part of efforts to lower drug costs and broaden treatment options for obesity and related conditions.
Topics:business#drug-prices#glp-1-medications#healthcare#medicare#obesity-drugs#trump-administration
- Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals CNN
- Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage CNBC
- Trump strikes deal to lower cost of Wegovy, Zepbound weight loss drugs NBC News
- President Trump on Lowering Price of Weight Loss Drugs C-SPAN
- WATCH: Trump announces deal to expand coverage, lower costs on obesity drugs PBS
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
92%
743 → 60 words
Want the full story? Read the original article
Read on CNN